GLP-1 GIP Glucagon Analogs
GLP-1 GIP Glucagon Analogs Therapy for Metabolic Health represents a new paradigm in understanding metabolic aging, which is not only characterized by weight gain but also by hormonal imbalances, insulin resistance, energy deficiency, and progressive cellular aging. Recently developed GLP-1, GIP, and glucagon analogues have ushered in a new era not only in obesity treatment, but also in achieving longevity by supporting metabolic flexibility, glycemic stability, and healthy biological aging.
GLP-1 Analogues: Strengthening Metabolic Balance
GLP-1 (Glucagon-like peptide-1) is an intestinal hormone that increases insulin secretion from the pancreas and regulates appetite. Its analogues remain active in the body for longer durations and offer the following benefits:
- Appetite control and satiety
- Weight loss and reduction of visceral fat
- Improvement in insulin resistance and HbA1c levels
- Reduction of cardiovascular risks
- Suppression of inflammation
Clinically used forms include Semaglutide (Ozempic®, Wegovy®) and Liraglutide (Saxenda®).
GIP and Glucagon: Combined Effect with Retatrutide
One of the new generation agents, Retatrutide, is a multi-hormone analogue that simultaneously activates GLP-1, GIP, and Glucagon receptors. This approach provides the following benefits:
- Increased fat burning, basal metabolic rate is raised
- Better preservation of muscle mass
- Enhanced cellular energy production (mitochondrial function)
- Metabolic flexibility is improved
This offers a new treatment paradigm not only for individuals looking to lose weight but also for those seeking to reduce biological age, suppress inflammation, and achieve longevity goals.
Applications in the Longevity Perspective
At BariatrikLab Longevity Clinic, these agents are integrated into personalized longevity goals, not only for weight control but also for the following conditions:
- Risk reduction in metabolic syndrome / pre-diabetes
- Optimization of fat-to-muscle ratio (preventive for sarcopenia)
- Neuroprotective effects to support brain health
- Prevention of weight regain after bariatric surgery
- Suppression of inflammatory markers (CRP, IL-6, TNF-a)
- Improvement of mitochondrial health and energy production
All these treatments are planned under medical supervision, integrated with the individual’s epigenetic profile, biological age, and chronic risk scores.
Clinical Protocols and Safety
The use of GLP-1 and other analogues is provided through standard doses or low-dose protocols (microdosing), following personalized algorithms with monitoring. If necessary, biochemical parameters (HbA1c, leptin, ghrelin, lipid profile, etc.) and epigenetic analyses are used to support the treatment plan.
Under the guidance of Prof. Dr. Halil Coşkun, with years of clinical experience and metabolic surgery expertise, these agents are applied to the right individual, at the right time, and with the right dosage.
